What is Bulkamid® injection therapy?

Bulkamid® injection therapy is used to treat Stress Urinary Incontinence.

Bulkamid® injection therapy is made from a homogeneous polyacrylamide hydrogel. Our gel contains 2.5% cross-linked polyacrylamide and 97.5% apyrogenic water. Bulkamid® injection therapy is sterile and biologically inactive.

Bulkamid® injection therapy is non-toxic, resistant to biodegradation, and cannot pass through biological membranes because of the large molecular size of the cross-linked polyacrylamide.

It is transparent, odourless, pH neutral and insoluble in all known solvents.

How soon do results appear?

The results obtained with Bulkamid® injection therapy are immediate, but some patients may need re-injection.

How does the injection take place?

A Bulkamid® Cystoscope has been specially developed to solve the problems that have dogged other injection techniques until present. The cystoscope gives the physician full control and enables a panoramic view of the urethra. This means that the cystoscope can be swivelled to precisely the correct position for each - normally 3 - bulking points.

Does it hurt?

Hardly, as the patient is locally anaesthetised.

How long do I have to be off work?

The Bulkamid® injection therapy procedure can be carried out as an out-patient procedure with two days sick-leave. Some people take a few days off, other return to work immediately.

Does Bulkamid® injection therapy move from the site of injection?

Bulkamid® injection therapy is migration resistant and become an integrated part of the body's own tissue.

Where is Bulkamid® injection therapy made?

Bulkamid® injection therapy is developed by Contura International A/S, Denmark and produced in Copenhagen, Denmark, by the healthcare company Ferrosan A/S.